DNA makes RNA, RNA makes protein, protein makes phenotype—was the guiding framework for understanding inheritance and disease ...

Methylation changes in microbiome-derived cfRNA enable more accurate CRC diagnosis than traditional DNA or abundance-based ...

A study from the University of Chicago introduces an RNA-based liquid biopsy that detects early-stage colorectal cancer with ...

No longer a mere assistant who carries out the commands of DNA, RNA takes the lead in emerging therapeutics.

Liquid biopsies are tests that detect signs of cancer through a simple blood draw. Unlike traditional biopsies, which require ...

"Based on insights from six in-depth reports, this review explores how breakthroughs in sequencing, RNAi, and viral vector technologies will shape the future of biotech through 2029.”Boston, July 07, ...

Viome Life Sciences, a leader in AI-powered, RNA-based molecular diagnostics and personalized nutrition, today announced a ...

Epitopea, a transatlantic cancer immunotherapeutics company, has announced the formation of a dedicated clinical team and the ...

New method maps RNA in cells at native locations, revealing spatial responses to signals and offering insight into disease ...

RetinalGenix Technologies Inc. OTCQB:RTGN (“RetinalGenix” or the “Company”), a pioneering developmental-stage company focused on ophthalmic screening, monitoring, pharmacogenetic mapping, and repurpos ...